Clinical Trials In El Paso

Discover hundreds of clinical trials in El Paso.
Search clinical trials in El Paso by condition or phase.

e.g. Respiratory Diseases

El Paso•Healthy volunteers: No

Filter results

Results: 988

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

San Antonio, Houston, Fort Worth, Dallasshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

Houston, Dallas, Austin, Birminghamshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Phase 3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Shenandoah, Houston, Arlington, Alabastershow 30 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Houston, Dallas, Little Rock, Anaheimshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

San Antonio, McKinney, Houston, Dallasshow 72 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

e.g. Respiratory Diseases

El Paso•Healthy volunteers: No

Filter results

Results: 988

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

San Antonio, Houston, Fort Worth, Dallasshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

Houston, Dallas, Austin, Birminghamshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Phase 3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Shenandoah, Houston, Arlington, Alabastershow 30 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Houston, Dallas, Little Rock, Anaheimshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

San Antonio, McKinney, Houston, Dallasshow 72 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo